These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 24903307

  • 1. Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee--adolescents' melanoma as a paradigm.
    Rose K, Senn S.
    Pharm Stat; 2014; 13(4):211-3. PubMed ID: 24903307
    [Abstract] [Full Text] [Related]

  • 2. Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?
    Rose K, Walson PD.
    Clin Ther; 2017 Feb; 39(2):253-265. PubMed ID: 28159363
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?
    Rose K, Walson PD.
    Paediatr Drugs; 2017 Dec; 19(6):515-522. PubMed ID: 28889403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
    Hwang TJ, Tomasi PA, Bourgeois FT.
    PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
    [Abstract] [Full Text] [Related]

  • 7. The European Regulation on medicines for paediatric use.
    Dunne J.
    Paediatr Respir Rev; 2007 Jun; 8(2):177-83. PubMed ID: 17574163
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases.
    Stefanska AM, Distlerová D, Musaus J, Olski TM, Dunder K, Salmonson T, Mentzer D, Müller-Berghaus J, Hemmings R, Veselý R.
    Arch Dis Child; 2017 Oct; 102(10):952-957. PubMed ID: 28554892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G.
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.
    Rose K, Kopp MV.
    Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999
    [Abstract] [Full Text] [Related]

  • 15. Three years of paediatric regulation in the European Union.
    Olski TM, Lampus SF, Gherarducci G, Saint Raymond A.
    Eur J Clin Pharmacol; 2011 Mar; 67(3):245-52. PubMed ID: 21286912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paediatric investigation plans for pain: painfully slow!
    Davies EH, Ollivier CM, Saint Raymond A.
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1091-7. PubMed ID: 20821198
    [Abstract] [Full Text] [Related]

  • 19. Who are the PDCO?
    Dempsey EM, Connolly K.
    Eur J Pediatr; 2014 Feb; 173(2):233-5. PubMed ID: 23925423
    [Abstract] [Full Text] [Related]

  • 20. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
    Mentzer D.
    Int J Pharm; 2014 Aug 05; 469(2):240-3. PubMed ID: 24613178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.